Apoptosis and heart failure: clinical relevance and therapeutic target

Area of Science:

• Cardiology
• Molecular Biology
• Pathophysiology

Background:

• Heart failure (HF) is a major cause of death, characterized by impaired heart function.
• Myocyte loss is a critical component in HF development.
• Apoptosis (programmed cell death) is now understood to play a significant role in HF pathogenesis.

Purpose of the Study:

• To review the clinical relevance of apoptosis in human and experimental heart failure.
• To highlight apoptosis as a potential therapeutic target for HF.
• To discuss advancements in anti-apoptotic interventions for myocardial conditions.

Main Methods:

• Literature review of studies on apoptosis in heart failure.
• Analysis of evidence supporting apoptosis's role in HF genesis.
• Examination of clinical and experimental data.

Main Results:

• Apoptosis is a significant contributor to myocyte loss in heart failure.
• Evidence supports apoptosis as a key mechanism in HF progression.
• Myocardial anti-apoptotic interventions show promise.

Conclusions:

• Apoptosis is a critical factor in heart failure pathogenesis.
• Targeting apoptosis represents a viable therapeutic strategy for HF.
• Further research into anti-apoptotic therapies is warranted for HF treatment.